Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI) (RIBS VI)
Prospective Study of Bioresorbable Vascular Scaffold Treatment in Patients With In-stent Restenosis
Sponsor: Abbott Medical Devices
A PHASE4 clinical study on Coronary In-stent Restenosis, this trial is ongoing. The trial is conducted by Abbott Medical Devices and has accumulated 10 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
Status: Not Yet Recruiting → Unknown Status
-
Feb 2019 — Jan 2021 [monthly]
Not Yet Recruiting PHASE4
▶ Show 5 earlier versions
-
Dec 2018 — Feb 2019 [monthly]
Not Yet Recruiting PHASE4
-
Nov 2018 — Dec 2018 [monthly]
Not Yet Recruiting PHASE4
-
Jun 2018 — Nov 2018 [monthly]
Not Yet Recruiting PHASE4
-
May 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE4
Status: Recruiting → Not Yet Recruiting
-
Jan 2017 — May 2017 [monthly]
Recruiting PHASE4
First recorded
Apr 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
- Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
- Instituto de Investigación Sanitaria Hospital Universitario de la Princesa
- Spanish Society of Cardiology
- Terumo Medical Corporation
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Badajoz, Spain , Barcelona, Spain , Granada, Spain , L'Hospitalet de Llobregat, Spain , León, Spain , Madrid, Spain , Majadahonda, Spain , Oviedo, Spain , San Cristóbal de La Laguna, Spain , Santander, Spain and 4 more locations